10:43 AM EST - HLS Therapeutics Inc. : Announces that Gilbert Godin, CEO, and Tim Hendrickson, CFO, will take part in a fireside chat with Stifel Healthcare analyst, Justin Keywood, at the 2022 Stifel Healthcare Conference on Wednesday November 16, at 8:35 a.m. Eastern Time. The conference is being held at the Lotte New York Palace Hotel in New York City. HLS Therapeutics Inc.
shares T.HLS are trading down $0.07 at $9.43.
